Trading Summary - April 5. A satisfactory status quo

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
157
Trading Summary - April 5.

A satisfactory status quo day for $EVSV.

Again today most of the top traders in the OTC were maxed out elsewhere taking advantage of a short squeeze on $OTTV and the continued shorts vs institutional buyer action on $VYST. For those that watched the $OTTV action as suggested here yesterday, when $EVSV is moved up it will be much thinner to the upside than $OTTV was (.0302 > .0439 yesterday - .0439 > .0850 today) as it has less shares available, all in the hands of savvy enthusiasts, and more no-brainer catalysts than $OTTV.

$EVSV remains the #1 Pick on the Watch List for profit earning potential in 2019.

As previously stated, the top traders in $EVSV are not going to waste our time playing in among the manipulation action apart from taking out asks when it suits us and maintaining a basher / flipper reload denial bid.

Today I and another trader ensured the status quo was maintained by topping up the bid at .5000 to counter paint downs. I also issued a warning that if the artificially low undercut ask at .5290 and .5299 was not removed by Monday, the morons who put it there can expect to lose their shares. We can expect some more traders will be moving profits from $VYST and $OTTV this week into $EVSV next week.

Today's action was:

- 60 buy at .5300 to test - manipulator lowered remainder to .5299.

- 50 shares paint down into visible bid at .5000.

- 35 + 75 bought to test walked down ask at .5299.

- 1,015 + 364 bought by 2 bidders via 2 x MMs at .5000 from paint downs - 364 to me - 1,015 to someone else.

- Bid at .5000 topped up.

- 200 buy at .5290 to test insignificant walked down ask.

- Bids remained in depth at unrealistic low prices at .4500 / .4600 below the 2 visible bidders at .5000.

- It is still the case - for the 5th day running - that traders need to hit the ask - as well as bidding - to even be able to get 10,000 shares in a day - let alone 100,000 as 2 are known to be trying for.

Overall, another 1,799 shares were bought today - all were in the "as near to .4000 / .0002 as makes no difference" range under the .6000 equivalent of .0003 in "old"money.

Next week, once the market cools down on $VYST & $OTTV, we can expect more Watch List followers - increasing every day due to the successful picks - to move into $EVSV and for the artificially low fake asks put up to suit the basher nonsense narrative to be taken out - as happened on $OTTV today.

This will remain the main board for analysis of trading action . I will make occasional posts on iHub to debunk nonsense and keep the correct analysis in my single Mod sticky and 1 > 3 Plus 1 slots.

I'll be updating the DD / Rolling Brief and Analysis of Loading At Bottom Price Levels over the weekend.

Items below the line unchanged from previous report and still valid [important points emphasized in bold]:

The DD / Rolling Brief, Analysis of Loading At Bottom Price Levels, and Weekly Trading Summary were all updated on March 31, 2019 and are to be found here:

https://investorshangout.com/post/view?id=5397959

https://investorshangout.com/post/view?id=5397942

https://investorshangout.com/post/view?id=5397740

A DD package - prepared by ericace2001 and also posted oniHub - is to be found here:

https://investorshangout.com/post/view?id=5382297

The share structure was updated as at the close on March 29, 2019 - again with no change - and again confirming no dilution.

The 2018 Annual Report was filed on time with improved financials.

Expect continued loading by stealth - with a mixture of hidden bids, visible large bids and ask hits - until the main traders in this are ready to move it up a bound or so - above .6000 initially.

Two iHub posters have now stated that that they will be buying 100K. Once they have completed their loading, they will be in the same league as myself and the other top traders who have loaded 100K+ each from January 14 onwards - I will be adding more pyramid fashion as we move up - within my "free" cost basis from previous banked profits.

Don't expect any significant amount to be offered under .6000 as it is not unreasonable to expect to see $1 to $2 at some point in 2019 based on the thin share structure, the majority of shares being in the hands of savvy traders, and multiple catalysts ahead such as additional pest control and DoD infrastructure contracts, the startup up of the hemp "fast cash earning" operation, and expansion into as many as 7 states.

Most of the main traders in the OTC - including me - are too busy to be bothered jockeying for position with the manipulators. We already have our core .4000s (or equivalent .0002s from January 14) and don't need to prioritize time on $EVSV until deciding to take out everything under 1.0000 when a suitable opportunity arises.

There is still very little in asks under .6000 and $EVSV should be extremely thin to 1.000+. Note how correct this has turned out to be !

Any one of the significant traders in $EVSV could move it to 1.000 single handed if they chose to. I might do it myself just to deny the cheap shares to the basher / manipulators on a day that is relatively inactive on my other top picks.

The top traders who are controlling the majority of the Float are happy to keep a wide bid/ask spread - as it will force new interest to hit the ask especially if / when a share buyback is announced - whilst maintaining a r/s level par backstop to absorb any nonsense paint downs from bashers to add to their inventory.

There are now 52 x social media alerters / analysts [up 15 in 10 days] that have $EVSV on their radar now for continued upward movement - as listed here:

https://investorshangout.com/post/view?id=5390650

There are now 5 x suspect duplicate ID bashers on iHub. They have provided more evidence for a SEC report and possible action by the Company Attorney by continuing with outright disinformation and defamation - particularly regarding the effect of the r/s and the CEO. They are so engrossed in repeating the same tired old nonsense - eg "shareholders wiped out" when in fact nobody was and competent traders should be 50% > 70% up already - that they fail to notice the actual trading action and / or not being competent traders don't know how to interpret the L2 information correctly.

Overall, $EVSV continues to play out exactly as I expected and suggested it would for those following my proven "trading through a r/s" strategy.

Ahead expect:

- Continued manual and further automatic outbidding.

- Closing of the spread and / or hitting the ask across a wide spread when an artificially low fake ask is seen.

- More hits on the ask from those that failed to load .0002/3/4 [.4000 > .8000] on January 14 before the r/s and who only have .0005 [1.000] and above.

- More bids at higher levels in the .5700 to .5900 range if they prove successful in weeding out a few impatient people.

- Further updates on the progress of entry into the hemp sector - particularly in the other 6 states being considered - as one of the company's diversification efforts.

- Further updates on a share buyback by the company.

- Update to the share structure between around April 12, 2019.

- Hemp website to go live in the coming days.

- Confirmation of hemp planting on / around April 30, 2019.







Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Systemair Shakes Things Up: Closing Netherlands Facility

Updated Category News Views 81

Systemair's Shocking Shutdown Decision Feels like we're strapped into a roller coaster with these HVAC companies lately. Systemair (NASDAQ Stockholm: SYSR) sure gave us quite the surprise ride by announcing they're pulling the plug on their production facility in Waalwijk, the Netherlands. This isn't just a ripple in a pond; it's a splash that might make some waves in the...

Continue Reading
Z Squared Eyes 150 MW Expansion at Arkansas Site

Updated Category News Views 23

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Continue Reading
OneMain Holdings' Q3 2026: Mixed Signals in Nonprime Sector

Updated Category News Views 35

Third Quarter Earnings: A Double-Edged Sword OneMain Holdings, Inc. (NYSE: OMF) rolled its Q3 2026 numbers out, and they look like a classic cocktail of high hopes and looming risks. On the surface, a diluted EPS of $1.60 might not sound like a knockout punch to the jaw, but let’s not forget they’ve taken a step back from last year’s $1.67. Their net income of $185...

Continue Reading
Cork's Market Power Surges in U.S. Wine Industry

Updated Category News Views 0

Cork: The Unsung Hero of the Wine Bottle You'd think a simple piece of bark couldn't shift the billion-dollar wine industry, but cork closures are doing just that. According to new NielsenIQ data, these natural stoppers are holding their ground as top dogs in the U.S. wine market. Who would've guessed that cork would drive the highest off-premise revenue? That's some...

Continue Reading
Human Judgment Crucial Amid AI Growth in Courts

Updated Category News Views 67

AI in the Justice System: Balancing Potential and Pitfalls You know, when it comes to upholding justice, there's a line between what machines can handle and what only a human can bring to the gavel. Chief Justice Sundaresh Menon of Singapore threw the spotlight on this at an event in Brisbane, hammering home the need for good ole human intuition in the courtroom even as...

Continue Reading
Benewake Unveils SR Series LiDAR for Mobile Robots

Updated Category News Views 34

Wave Goodbye to Bulky Sensors Hot off the Beijing press, Benewake's got something new—the SR Series 360° 3D LiDARs, set to stir up the robotics world. They're compact, power-efficient, and packed with smarts. It seems Benewake is tapping into a juicy market with these little sensors. Sleek Design and Big Promises The SR18 and SR96 models have a lot going for them. The...

Continue Reading
Furniture Quality: Expert Tips for Savvy Shoppers

Updated Category News Views 0

Picking Apart Furniture Quality Before a Purchase In a world where cheap and flashy often overshadow durability, knowing what makes furniture stand the test of time isn't just wise—it's essential. Learn from Nate Bartlett, the furniture sage from Charlevoix, Michigan, who guides shoppers through the maze of quality indicators in a recent HelloNation article. If you're...

Continue Reading
Webull Faces Class Action: Investor Impact Deep Dive

Updated Category News Views 129

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 53

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Phrontline's TJ101 Gains Momentum in Cancer Clinical Trials

Updated Category News Views 75

Encouraging Signs from Phrontline's TJ101 ADC Trials In the high-stakes race to outsmart cancer, Phrontline Biopharma is banking on TJ101, their star investigational bispecific antibody-drug conjugate (ADC). The recent results shared at the ESMO Congress 2026 are stirring up quite a bit of chatter. Urothelial Carcinoma and Beyond Now, picture this: six of eight evaluable...

Continue Reading

Top 5 Most Recently Viewed Articles

BridgeBio Pharma Set to Showcase Innovations at Conference

Updated Category News Views 166

BridgeBio Pharma Announces Participation in Key Healthcare Conference BridgeBio Pharma, Inc. (NASDAQ: BBIO), a pioneering biopharmaceutical company committed to genetic disease research, has announced its participation in a major healthcare conference. During this significant event, co-founder and CEO, Neil Kumar, Ph.D., will take center stage to share insights into the...

Continue Reading
Experience the Artistry of the Sistine Chapel in Austin

Updated Category News Views 197

The Unveiling of the Sistine Chapel Experience in Austin Prepare to embark on an extraordinary journey through art and culture with the grand reveal of The Sistine Chapel Experience. This captivating digital reconstruction of Michelangelo's monumental frescoes brings the exquisite details of this historical masterpiece to life like never before. Located at the Barton...

Continue Reading
Aurora Spine Launches Innovative AERO™ Lumbar Fusion System

Updated Category News Views 148

Aurora Spine Introduces the AERO™ Lumbar Fusion System Aurora Spine Corporation has taken a significant step forward in the realm of spinal health solutions with the announcement of surgeries using its newly launched AERO™ Lumbar Fusion System. The initial surgeries were conducted by both an orthopedic surgeon and an interventionalist, marking a crucial milestone in...

Continue Reading
Pyxis Oncology Advances PYX-201 Trials for Cancer Treatment

Updated Category News Views 166

Exciting Developments at Pyxis Oncology In the realm of oncology, advancements in treatment options can spark hope for many patients facing difficult diagnoses. Pyxis Oncology, Inc., a company at the forefront of next-generation cancer therapies, has recently announced exciting progress in their clinical trials featuring PYX-201. This innovative drug represents potential...

Continue Reading
Skanska Secures Major Surgery Center Contract with Sutter Health

Updated Category News Views 371

Skanska's New Contract with Sutter Health Skanska has successfully signed a significant contract with Sutter Health to develop an ambulatory surgery center and a specialty clinic. This project holds a contract value of USD 55 million, approximately SEK 600 million, and it will positively impact the order bookings in the US for early 2025. Project Overview and Features The...

Continue Reading